HomeCompareLVSDF vs JNJ

LVSDF vs JNJ: Dividend Comparison 2026

LVSDF yields 4000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LVSDF wins by $206.74M in total portfolio value
10 years
LVSDF
LVSDF
● Live price
4000.00%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$206.77M
Annual income
$4,025,981.19
Full LVSDF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — LVSDF vs JNJ

📍 LVSDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLVSDFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LVSDF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LVSDF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LVSDF
Annual income on $10K today (after 15% tax)
$340,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,422,084.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, LVSDF beats the other by $3,418,098.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LVSDF + JNJ for your $10,000?

LVSDF: 50%JNJ: 50%
100% JNJ50/50100% LVSDF
Portfolio after 10yr
$103.40M
Annual income
$2,015,335.30/yr
Blended yield
1.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LVSDF
No analyst data
Altman Z
-0.1
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LVSDF buys
0
JNJ buys
0
No recent congressional trades found for LVSDF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLVSDFJNJ
Forward yield4000.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$206.77M$30.3K
Annual income after 10y$4,025,981.19$4,689.40
Total dividends collected$154.59M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LVSDF vs JNJ ($10,000, DRIP)

YearLVSDF PortfolioLVSDF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$210,700$200,000.00$10,592$272.30+$200.1KLVSDF
2$2,194,608$1,969,158.88$11,289$357.73+$2.18MLVSDF
3$11,932,508$9,584,277.57$12,123$472.89+$11.92MLVSDF
4$37,118,986$24,351,202.37$13,141$629.86+$37.11MLVSDF
5$75,114,686$35,397,370.81$14,408$846.81+$75.10MLVSDF
6$113,845,047$33,472,333.01$16,021$1,151.60+$113.83MLVSDF
7$145,520,376$23,706,175.51$18,122$1,588.22+$145.50MLVSDF
8$169,866,611$14,159,808.80$20,930$2,228.20+$169.85MLVSDF
9$189,481,017$7,723,743.28$24,792$3,191.91+$189.46MLVSDF
10$206,770,669$4,025,981.19$30,274$4,689.40+$206.74MLVSDF

LVSDF vs JNJ: Complete Analysis 2026

LVSDFStock

Lai Sun Development Company Limited, together with its subsidiaries, invests in, develops, leases, and sells real estate properties in Hong Kong, Mainland China, Macau, the United Kingdom, Vietnam, and internationally. It operates through Property Development and Sales; Property Investment; Hotel Operation; Restaurant and F&B Product Sales Operations; Media and Entertainment; Film and TV Program; Cinema Operation; Theme Park Operation; and Others segments. The company also invests in, develops, operates in, and manages cultural, leisure, entertainment, and related facilities; operates hotels and restaurants; and provides management and consultancy services to hotels, serviced apartments, and restaurants. In addition, it engages in the development, operation, and investment of media and entertainment events; cinema operations; golf apparel retailing; and music production and distribution, as well as provision of related advertising services. Further, the company invests in, produces, licenses, and distributes television programs, films, and video format products. Additionally, the company offers property management, real estate agency, leasing agency, performance agency, and building services; and luxury yachts brokerage, charter, marketing, management, and crew placement services; and finance and treasury services. It also provides artiste management services; sells albums; distributes and licenses music and film rights; and trades in gaming products. In addition, the company distributes movie digital video discs and Blu-ray discs. Further, it engages in the film library management; provision of video duplication services; translating and subtitling of television programs; and selling of beverage products. The company was incorporated in 1959 and is headquartered in Central, Hong Kong. Lai Sun Development Company Limited is a subsidiary of Lai Sun Garment (International) Limited.

Full LVSDF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this LVSDF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LVSDF vs SCHDLVSDF vs JEPILVSDF vs OLVSDF vs KOLVSDF vs MAINLVSDF vs ABBVLVSDF vs MRKLVSDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.